BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3285181)

  • 1. Two-step stimulation of B lymphocytes to enter DNA synthesis: synergy between anti-immunoglobulin antibody and cytochalasin on expression of c-myc and a G1-specific gene.
    Buckler AJ; Rothstein TL; Sonenshein GE
    Mol Cell Biol; 1988 Mar; 8(3):1371-5. PubMed ID: 3285181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic alkalinization produced by the combination of anti-immunoglobulin antibody plus cytochalasin D in murine B lymphocytes.
    van Haelst-Pisani C; Cragoe EJ; Rothstein TL
    Exp Cell Res; 1989 Jul; 183(1):251-6. PubMed ID: 2786816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
    Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
    J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cell-cycle-dependent genes in serum stimulated cells whose entry into S phase is blocked by cytochalasin D.
    Takasuka T; Ishibashi S; Ide T
    Biochim Biophys Acta; 1987 Jul; 909(2):161-4. PubMed ID: 3297158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
    Golay J; Cusmano G; Introna M
    J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early stimulation by EGF plus insulin of rRNA, c-fos, and actin mRNA expression: inhibition by cytochalasin D.
    Rebillard M; Leibovitch S; Jullien M; Talha S; Harel L
    Exp Cell Res; 1987 Oct; 172(2):432-8. PubMed ID: 3115801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
    Klemsz MJ; Justement LB; Palmer E; Cambier JC
    J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of B cells by sequential addition of anti-immunoglobulin antibody and cytochalasin.
    Rothstein TL
    J Immunol; 1986 Feb; 136(3):813-6. PubMed ID: 3484500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of c-myc expression in human B lymphocytes by B-cell growth factor and anti-immunoglobulin.
    Lacy J; Sarkar SN; Summers WC
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1458-62. PubMed ID: 3513176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the time of entry into S is determined by events occurring in early G1.
    Cosenza SC; Owen TA; Soprano DR; Soprano KJ
    J Biol Chem; 1988 Sep; 263(25):12751-8. PubMed ID: 3137230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GC-7 cells are growth arrested by cytochalasin D at two different points in the cell cycle.
    Takasuka T; Ishibashi S; Ide T
    Exp Cell Res; 1987 Nov; 173(1):287-93. PubMed ID: 3119358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant immunoglobulin and c-myc gene rearrangements in patients with nonmalignant monoclonal cryoglobulinemia.
    Perl A; Wang N; Williams JM; Hunt MJ; Rosenfeld SI; Condemi JJ; Packman CH; Abraham GN
    J Immunol; 1987 Nov; 139(10):3512-20. PubMed ID: 3316385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
    Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional control of c-myc gene expression during stimulation of murine B lymphocytes.
    Buckler AJ; Rothstein TL; Sonenshein GE
    J Immunol; 1990 Jul; 145(2):732-6. PubMed ID: 2195118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle.
    Reilly CF; Kindy MS; Brown KE; Rosenberg RD; Sonenshein GE
    J Biol Chem; 1989 Apr; 264(12):6990-5. PubMed ID: 2651437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of c-myc and c-jun proto-oncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene.
    Abshire MK; Buzard GS; Shiraishi N; Waalkes MP
    J Toxicol Environ Health; 1996 Jul; 48(4):359-77. PubMed ID: 8691507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
    Schauer SL; Wang Z; Sonenshein GE; Rothstein TL
    J Immunol; 1996 Jul; 157(1):81-6. PubMed ID: 8683159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA; Reinherz EL
    J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens.
    Schneider-Schaulies J; Hünig T; Schimpl A; Wecker E
    Eur J Immunol; 1986 Mar; 16(3):312-6. PubMed ID: 3514240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.